Completed PHASE4 INTERVENTIONAL 2-arm NCT00719056

Teicoplanin Prophylaxis for Total Hip or Knee Arthroplasty

Efficacy of Teicoplanin for the Prevention of Surgical Site Infections After Total Hip or Knee Arthroplasty: A Prospective, Open-Label Randomized Study

Sponsor: KAT Hospital of Athens

Conditions Total Hip and Knee Arthroplasties

Interventions Teicoplanin β-lactams or ciprofloxacin

Updated 6 times since 2017 Last updated: Jul 18, 2008 Started: Aug 31, 2004 Primary completion: Dec 31, 2005 Completion: Dec 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Total Hip and Knee Arthroplasties, this trial is completed. The trial is conducted by KAT Hospital of Athens and has accumulated 6 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Aug 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

KAT Hospital of Athens
University of Athens

Data source: University of Athens

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Marousi, Greece